Background: Aortic Dissection (AD) is a life-threatening condition and one of the major causes of death in the U.S. Despite its clinical significance, trends in AD related mortality remain understudied. We aim to analyze nationwide mortality trends in AD in the U.S. Methods: Data from CDC WONDER (1999–2024) identified U.S mortality rates in adults aged ≥ 25 years with AD (ICD-10: I71.0). Crude mortality rates (CMRs) and age-adjusted mortality rates (AAMRs) per 100,000 were calculated. Trends were analyzed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Results: From 1999 to 2024, a total of 115,449 deaths from AD were recorded. The AAMR increased from 2.1 in 1999 to 2.4 in 2024 (AAPC of 0.46; 95% CI: 0.31 to 0.61; p < 0.001). Men had higher mortality than women (Overall AAMR: 2.62; p < 0.001 vs. 1.45; p < 0.001) (AAPC: 0.22; 95% CI: 0.05 to 0.39 vs. 0.61; 95% CI: 0.42 to 0.83) respectively. Racially, non-Hispanic (NH) Blacks demonstrated the greatest overall AAMR of 3.11. Regionally, AAMRs were highest in the Midwest (2.17) followed by the West (2.14). The urban areas had higher overall AAMRs than the rural areas (1.95, p = 0.27 vs. 1.90, p = 0.074). The majority of deaths occurred in medical facilities (88,976 deaths, 77.06%) and in older adults with CMR (5.8). Conclusion: Mortality trends in AD increased from 1999 to 2024. Higher trends occurred in men, urban areas, Midwest region, NH Black population and medical facilities.
Background: Acute myocardial infarction (AMI) with essential hypertension (EH) and secondary hypertension (SH) remains a leading cause of mortality. Despite the overall decline, disparities in mortality trends across age group, gender, urbanization, racial, and regional subgroups remain underexplored. Methods: Mortality data from the CDC WONDER (2000–2024) were analyzed for AMI (ICD‐10 I21) as the primary cause of death and EH (ICD‐10 I10) and SH (ICD‐10 I15.0, I15.9) as a contributing factor in individuals aged ≥ 25 years. Age‐adjusted mortality rates (AAMRs) were standardized to the US 2000 population. Joinpoint regression estimated annual percentage changes (APCs) with 95% confidence intervals (CIs). Results: AMI with hypertension caused 842,646 deaths, with AAMR declining from 17.63 in 2000 to 12.26 in 2024. Overall, the AAMR showed a significant decline across the study period (AAPC: −1.71%). Males consistently had a higher mean AAMR (18.50) than females (11.82). Upward inflections were noted in the South region during 2018–2021 (APC: 11.17%; p = 0.004), Non‐Hispanic Black individuals during 2018–2021 (APC: 9.45%; p = 0.053), metropolitan areas during 2018–2020 (APC: 7.71%; p = 0.038), and among adults aged 65–74 years during 2018–2021 (APC: 7.15%; p = 0.039). State‐level variations were observed. Conclusion: Despite the overall decline, rising mortality trends were observed in the Southern region (2018–2021), metropolitan areas, and among individuals aged 65–74 years, highlighting emerging patterns and emphasizing the need for targeted interventions.
Introduction: Patients with co‐existing type 2 diabetes mellitus (T2DM) and ischemic heart disease (IHD) face a higher mortality risk than those with either condition alone. We examined US mortality trends and disparities in adults with both conditions, 1999–2024. Methods: CDC WONDER death certificate data were used to identify adults aged ≥ 45 years with both T2DM (ICD‐10 E11) and IHD (I20–I25) listed as underlying or contributing causes. Age‐adjusted mortality rates (AAMRs) per 100 000 were calculated, and trends were assessed with Joinpoint regression (permutation test) to estimate annual percent change (APC) and average annual percent change (AAPC). Results: T2DM and IHD were co‐listed on 828 250 death certificates. The AAMR rose from 18.87 in 1999 to 37.65 in 2021 and was 32.97 in 2024 (AAPC 2.06%; 95% CI, 1.68–2.61). AAMRs increased until 2005 (APC 3.51%), declined until 2015 (APC −0.93%), surged until 2021 (APC 9.06%), and declined thereafter (APC −4.04%). AAMRs were higher in males than females (36.33 vs. 18.53) and highest among non‐Hispanic American Indian or Alaska Native adults (44.27). Age‐specific rates rose from 2.74 (45–54 years) to 149.59 (≥ 85 years). AAMRs were higher in non‐metropolitan than metropolitan areas (30.89 vs. 22.59; 1999–2020) and highest in the West (31.24) and Midwest (30.57). Conclusions: AAMRs increased overall from 1999 to 2024 despite a decline after 2021, with marked demographic and geographic disparities. Targeted interventions and equitable access to cardioprotective therapies are needed for high‐risk populations.